Archive
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
AstraZeneca gets fresh designation for Enhertu while Imfinzi trial fizzles
Mon 22 December 2025 08:52
(Sharecast News) - AstraZeneca on Monday reported mixed regulatory and clinical news, with its breast cancer drug Enhertu securing a US breakthrough therapy designation in early disease, while a late-stage lung cancer trial of ceralasertib in combination
CLS agrees conditional sale of Vauxhall's Citadel Place
Mon 22 December 2025 08:04
(Sharecast News) - CLS Holdings has announced the exchange of contracts for the conditional sale of Citadel Place in Vauxhall, London, to residential developer London Square on Monday, as the two parties moved forward with plans for a residential-led rede